Pulsed Electromagnetic Field (PEMF) Device Study

What is the purpose of the study?

The purpose of this study is to investigate the effects that treating the brain with a pulsed electromagnetic field (PEMF) device
(the ECHS™ AD Device) could have in the treatment of Alzheimer’s Disease and Related Dementias (AD/ADRD).

Who can participate in this study?

You must be:

50 years or older.

Diagnosed with mild to moderate dementia including Alzheimer’s disease, Lewy body dementia, and vascular dementia.

Achieved at least an eighth-grade level of education.

Able to wear a headband-type device 2 to 3 times a day, for 15 minutes each time.

How long will the study last?

Your participation in this study will be 180 days with 5 in-person visits, once every 45 days.

Why should I participate in the study?

This study will show what, if any, positive effects that a Pulsed Electromagnetic Field (PEMF) treatment via a new innovative noninvasive wearable device will have on your dementia. PEMF therapy devices utilize a therapeutic electrical field to target cells and tissues.

What is a clinical research study?

It is voluntary participation in a study conducted in people and designed to answer specific questions about the safety or effectiveness of drugs, vaccines, devices, other therapies, or new ways of using existing treatments. As outlined above, our device has no known health risks.

For additional study information, please contact: Shanell Disla (Research Coordinator).

Phone: 561-869-6825

Email: 2xd1210@med.miami.edu